TABLE 1.
Diagnostic test | Optimal cut‐off | AUROC | Sensitivity | Specificity | PPV | NPV |
---|---|---|---|---|---|---|
BAT 0.01 ng/ml (% CD63) | 2.00 | 0.75 | 0.49 | 0.96 | 0.97 | 0.42 |
BAT 0.1 ng/ml (% CD63) | 2.61 | 0.92 | 0.84 | 0.96 | 0.98 | 0.70 |
BAT 1 ng/ml (% CD63) | 2.50 | 0.96 | 0.94 | 0.93 | 0.97 | 0.86 |
BAT 10 ng/ml (% CD63) | 13.06 | 0.99 | 0.93 | 1.00 | 1.00 | 0.84 |
BAT 100 ng/ml (% CD63) | 5.59 | 0.95 | 0.94 | 0.89 | 0.96 | 0.86 |
BAT 1000 ng/ml (% CD63) | 17.10 | 0.84 | 0.84 | 0.74 | 0.89 | 0.65 |
Hoxb8 MAT 0.01 ng/ml (% CD107a) | 1.02 | 0.52 | 0.49 | 0.63 | 0.77 | 0.33 |
Hoxb8 MAT 0.1 ng/ml (% CD107a) | 1.13 | 0.52 | 0.71 | 0.44 | 0.77 | 0.38 |
Hoxb8 MAT 1 ng/ml (% CD107a) | 1.24 | 0.73 | 0.72 | 0.63 | 0.83 | 0.47 |
Hoxb8 MAT 10 ng/ml (% CD107a) | 1.98 | 0.92 | 0.80 | 0.96 | 0.98 | 0.65 |
Hoxb8 MAT 100 ng/ml (% CD107a) | 2.58 | 0.97 | 0.91 | 0.96 | 0.98 | 0.81 |
Hoxb8 MAT 1000 ng/ml (%CD107a) | 5.20 | 0.97 | 0.93 | 0.96 | 0.98 | 0.84 |